Sun Pharma Advanced Research Company LimitedEigentümerstruktur
| Preis (2025-07-29) | 52W Hoch | 52W Tief |
| 153.53 INR | 241 INR | 109,3 INR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - INR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 324.521.984 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Sun Pharma Advanced Research Company Limited
Mitarbeiter 316
Handelsplatz NSE
Ticker Symbol SPARC
IPO Datum -
Adresse 17/B, Mahal Industrial Estate, Mumbai, India, 400093
Webseite https://sparc.life
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Anilkumar Raghavan | Chief Executive Officer |
| 2 | Mr. Anup Rathi | Chief Financial Officer |
| 3 | Dr. Nitin Dharmadhikari | Chief Operating Officer |
| 4 | Mr. Jaydeep Issrani | Senior General Manager of Business Development, Corporate Communication & Investor Relations |
| 5 | Ms. Kajal K. Damania | Company Secretary & Compliance Officer |
| 6 | Ms. Shanta Gupta | Chief Human Resource Officer |
| 7 | Mr. Siu-Long Yao | Head Clinical Development |
| 8 | Dr. Nitin K. Damle Ph.D. | Executive VP of Biologics & Chief Innovation Officer |
| 9 | Dr. Yashoraj Zala | Head of Drug Delivery Systems |
| 10 | Dr. Vikram K. Ramanathan | Head of Drug Discovery & Preclinical Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.